Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cleveland

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Cancer Research|September 13, 2023
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple MyelomaKaren L Burger, Mario R Fernandez, Mark B Meads, et al.
Cancer Cell|August 22, 2025
Lymphoma accelerates T cell and tissue agingRebecca S Hesterberg, Joshua T Davis, Komal J Handoo, et al.
Blood Cancer Discovery|May 7, 2024
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin AxisNicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, et al.
Cancer Cell|May 16, 2019
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma ModelsXiaohong Zhao, Yuan Ren, Matthew Lawlor, et al.
Blood|May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytesRebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Blood|June 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple MyelomaJerald D Noble, Barbara C Peixoto, Meghan A Menges, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cell Reports|October 3, 2019
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Christina Bruss, Annette Schnell, et al.
Cancer Research|October 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple MyelomaPraneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Cancer Research|September 13, 2023
CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple MyelomaKaren L Burger, Mario R Fernandez, Mark B Meads, et al.
Cancer Cell|August 22, 2025
Lymphoma accelerates T cell and tissue agingRebecca S Hesterberg, Joshua T Davis, Komal J Handoo, et al.
Blood Cancer Discovery|May 7, 2024
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin AxisNicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, et al.
Cancer Cell|May 16, 2019
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma ModelsXiaohong Zhao, Yuan Ren, Matthew Lawlor, et al.
Blood|May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytesRebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Research Square|May 5, 2025
Epigenetic Plasticity Drives Carcinogenesis and Multi-Therapy Resistance in Multiple MyelomaRafael Renatino Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Blood|June 11, 2026
Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple MyelomaJerald D Noble, Barbara C Peixoto, Meghan A Menges, et al.
Cancer Research|June 3, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple MyelomaRafael R Canevarolo, Praneeth Reddy Sudalagunta, Mark B Meads, et al.
Cell Reports|October 3, 2019
Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint TherapyKathrin Renner, Christina Bruss, Annette Schnell, et al.
Cancer Research|October 30, 2024
The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple MyelomaPraneeth Reddy Sudalagunta, Rafael R Canevarolo, Mark B Meads, et al.
Pageof 16